Bibliography | 1.Sakibuzzaman M, Moosa SA, Akhter M, Trisha IH, Talib KA. Identifying the Neurogenetic Framework of Crohn's Disease Through Investigative Analysis of the Nucleotide-binding Oligomerization Domain-containing Protein 2 Gene Mutation. Cureus. 2019 Sep 17;11(9):e5680. doi: 10.7759/cureus.5680. PMID: 31723489; PMCID: PMC6825438. 2.Vlacil AK, Schuett J, Ruppert V, Soufi M, Oberoi R, Shahin K, Wächter C, Tschernig T, Lei Y, Liu F, Tietge UJF, Schieffer B, Schuett H, Grote K. Deficiency of Nucleotide-binding oligomerization domain-containing proteins (NOD) 1 and 2 reduces atherosclerosis. Basic Res Cardiol. 2020 Jun 25;115(4):47. doi: 10.1007/s00395-020-0806-2. PMID: 32588196; PMCID: PMC7316681. 3.NOD1 and NOD2: signaling, host defense, and inflammatory disease.
Caruso R, Warner N, Inohara N, Núñez G
Immunity. 2014 Dec 18; 41(6):898-908. 4.NOD1 and NOD2: Molecular targets in prevention and treatment of infectious diseases.
Pashenkov MV, Dagil YA, Pinegin BV
Int Immunopharmacol. 2018 Jan; 54():385-400 |